• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Severe COVID-19 disease is associated with genetic factors affecting plasma ACE2 receptor and CRP concentrations

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Feb 8;15(1):4708.
doi: 10.1038/s41598-025-89306-4. Severe COVID-19 disease is associated with genetic factors affecting plasma ACE2 receptor and CRP concentrations

Verena Vogi[SUP] #[/SUP][SUP] 1 [/SUP], David Haschka[SUP] #[/SUP][SUP] 2 [/SUP], Lukas Forer[SUP] 3 [/SUP], Simon Schwendinger[SUP] 1 [/SUP], Verena Petzer[SUP] 4 [/SUP], Stefan Coassin[SUP] 3 [/SUP], Ivan Tancevski[SUP] 2 [/SUP], Thomas Sonnweber[SUP] 2 [/SUP], Judith Löffler-Ragg[SUP] 2 [/SUP], Elisabeth Puchhammer-Stöckl[SUP] 5 [/SUP], Marianne Graninger[SUP] 5 [/SUP], Dominik Wolf[SUP] 4 [/SUP], Florian Kronenberg[SUP] 3 [/SUP], Johannes Zschocke[SUP] 1 [/SUP], Emina Jukic[SUP] #[/SUP][SUP] 6 [/SUP], Günter Weiss[SUP] #[/SUP][SUP] 7 [/SUP]



Affiliations
Abstract

A hyperinflammatory state with highly elevated concentrations of inflammatory biomarkers such as C-reactive protein (CRP) is a characteristic feature of severe coronavirus disease 2019 (COVID-19). To examine a potential role of common genetic factors that may influence COVID-19 outcomes, we investigated whether individuals with a polygenic predisposition for a pro-inflammatory response (in the form of Polygenic Scores) are more likely to develop severe COVID-19. The innovative approach of polygenic scores to investigate genetic factors in COVID-19 severity should provide a comprehensive approach beyond single-gene studies. In our cohort of 156 patients of European ancestry, two overlapping Polygenic Scores (PGS) predicting a genetic predisposition to basal CRP concentrations were significantly different between non-severe and severe COVID-19 cases and were associated with less severe COVID-19 outcomes. Furthermore, specific single nucleotide polymorphisms (SNPs) that contribute to either of the two Polygenic Scores predicting basal CRP levels are associated with different traits that represent risk factors for COVID-19 disease initiation (ACE2 receptor, viral replication) and progression (CRP). We suggest that genetically determined enforced CRP formation may contribute to strengthening of innate immune responses and better initial pathogen control thereby reducing the risk of subsequent hyperinflammation and adverse course of COVID-19.


 
Back
Top